Clinical trial Recruiting at 1 site Observational Ages 40 and up

Thromboxane A2 and Osteoarthritis

Official title: Throboxane Effect on Chondrocytes; Role in Osteoarthritis

Run by Centre Hospitalier Universitaire de Nice · NCT05593640 · Data updated 2026-11-12

Researchers are testing whether thromboxane A2 affects cartilage cells and osteoarthritis in humans and animals to see if it could help explain cartilage health and point toward new therapies.

Quick facts

Study typeObservational
Ages40 Years and up
SexAll
Enrollment20 (estimated)
SponsorCentre Hospitalier Universitaire de Nice
Academic / other
Locations1 site (Nice)
StatusRecruiting
StartedSeptember 1, 2022
Main results expectedSeptember 1, 2023
Study endsJune 25, 2027
Registry record updatedJune 29, 2026
Trial IDNCT05593640 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with knee osteoarthritis and effusion who are not on anticoagulants and do not have other inflammatory diseases.

Probably not a fit

Patients without knee OA or with inflammatory diseases or on anticoagulants may not benefit from this research.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates how thromboxane A2 (TXA2) influences chondrocyte differentiation and cartilage homeostasis. It includes in vitro experiments, a rat OA model to relate TXA2 levels with disease progression, and a small human cohort to examine associations between TXA2 in blood and synovial fluid with OA features. The study compares TXA2 effects to prostacyclin, another arachidonic acid metabolite, on thermogenic markers and cartilage biology. Results could inform nutritional or pharmacological approaches to OA and related metabolic conditions. The research is led by CHU de Nice with collaboration from the French Society of Rheumatology.

Why it matters

Potential benefit: If TXA2 pathways are linked to cartilage health, insights could lead to new strategies to slow OA progression or alleviate symptoms.

How similar studies have gone: Previous work has explored lipid metabolites in joint biology, but this specific TXA2–chondrocyte link in OA is exploratory and not yet established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* presence of knee osteoarthritis with effusion, , no inflammatory disease

Exclusion Criteria:

* anticoagulant treatment
* inflammatory disease

Where it's running

  • CHU de NICE
    Nice, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.